Company profile

Vincent A. Forlenza
Incorporated in
Fiscal year end
IRS number

BDX stock data



6 Aug 19
23 Oct 19
30 Sep 20


Company financial data Financial data

Quarter (USD) Jun 19 Mar 19 Dec 18 Sep 18
Revenue 4.35B 4.2B 4.16B 4.4B
Net income 451M 20M 599M -135M
Diluted EPS 1.51 -0.07 2.05 -0.64
Net profit margin 10.37% 0.48% 14.40% -3.07%
Operating income 626M 136M 888M 564M
Net change in cash -163M -257M -197M -244M
Cash on hand 523M 686M 943M 1.14B
Cost of revenue 2.28B 2.22B 2.19B 2.32B
Annual (USD) Sep 18 Sep 17 Sep 16 Sep 15
Revenue 15.98B 12.09B 12.48B 10.28B
Net income 311M 1.1B 976M 695M
Diluted EPS 0.6 4.6 4.49 3.35
Net profit margin 1.95% 9.10% 7.82% 6.76%
Operating income 1.5B 1.48B 1.43B 1.07B
Net change in cash -13.04B 12.64B 117M -437M
Cash on hand 1.14B 14.18B 1.54B 1.42B
Cost of revenue 8.72B 6.15B 6.49B 5.59B

Financial data from company earnings reports

Financial report summary

Management Discussion
  • Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
  • Becton, Dickinson and Company (“BD”) is a global medical technology company engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The Company's organizational structure is based upon three principal business segments, BD Medical (“Medical”), BD Life Sciences (“Life Sciences”) and BD Interventional (“Interventional”).
  • BD’s products are manufactured and sold worldwide. Our products are marketed in the United States and internationally through independent distribution channels and directly to end-users by BD and independent sales representatives. We organize our operations outside the United States as follows: Europe; EMA (which includes the Commonwealth of Independent States, the Middle East and Africa); Greater Asia (which includes Japan and Asia Pacific); Latin America (which includes Mexico, Central America, the Caribbean, and South America); and Canada. We continue to pursue growth opportunities in emerging markets, which include the following geographic regions: Eastern Europe, the Middle East, Africa, Latin America and certain countries within Asia Pacific. We are primarily focused on certain countries whose healthcare systems are expanding.
Content analysis ?
H.S. sophomore Avg
New words: behalf, Brexit, Chapter, Code, duly, earliest, earned, Euro, eXtensible, formal, formatted, indirect, Inline, instability, iv, iXBRL, Language, medium, merger, outlook, preferred, President, private, proactive, refinancing, responsabilit, shareholder, subsidiary, synergy, thereunto, unconditionally, undersigned, Vice, weather
Removed: British, Human, Inspector, reclassification, subpoena